Two interesting events followed my February commentary, “Cleveland: The next biotech hub?” First, readers began to contact me to show support for my argument that with some effort and organization, multi-challenged Cleveland could become the next Research Triangle Park... [
more ]
It doesn’t take a very elegant sensor to detect the current general malaise. Those of us who are old enough to have suffered a half-dozen such cycles know that we’ve come out of them by focusing on and delivering on innovation... [
more ]
by Peter T. Kissinger
Pharmaceutical manufacturers are under increased pressure to differentiate new drugs from those already on the market... [
more ]
